Dossier assessment
Ibrutinib (new therapeutic indication) - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)
Project details
- Project no.
- G15-07
- Commission
- Commission awarded on 01.08.2015 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Withdrawn commission
- Department/Division
- Health Economics
- Topic
- Cancer
- Note
-
The commission was withdrawn by the Federal Joint Committee in agreement with IQWiG on 15.10.2015. G-BA documents on this decision
Connected Projects
-
Dossier assessment
Ibrutinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)
Status: Commission completed
-
Dossier assessment
Ibrutinib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed
-
Dossier assessment
Ibrutinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed
-
Dossier assessment
Ibrutinib - Benefit assessment according to §35a Social Code Book V
Status: Commission completed